Last reviewed · How we verify

TNF alpha inhibitors — Competitive Intelligence Brief

TNF alpha inhibitors (TNF alpha inhibitors) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: TNF alpha inhibitor. Area: Immunology.

marketed TNF alpha inhibitor TNF-α (tumor necrosis factor-alpha) Immunology Small molecule Live · refreshed every 30 min

Target snapshot

TNF alpha inhibitors (TNF alpha inhibitors) — Prof. Roberto Giacomelli. TNF alpha inhibitors block tumor necrosis factor-alpha, a key inflammatory cytokine that drives immune-mediated inflammation.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
TNF alpha inhibitors TARGET TNF alpha inhibitors Prof. Roberto Giacomelli marketed TNF alpha inhibitor TNF-α (tumor necrosis factor-alpha)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (TNF alpha inhibitor class)

  1. Prof. Roberto Giacomelli · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TNF alpha inhibitors — Competitive Intelligence Brief. https://druglandscape.com/ci/tnf-alpha-inhibitors. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: